Ignite Creation Date:
2024-05-06 @ 3:18 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04599465
Status:
COMPLETED
Last Update Posted:
2023-08-03
First Post:
2020-10-21
Brief Title:
A Study to Assess the Effect of ELXTEZIVA on Glucose Tolerance in Participants With Cystic Fibrosis CF
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Vertex Pharmaceuticals Incorporated
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-14
Completion Date Type:
ACTUAL
First Submit Date:
2020-10-21
First Submit QC Date:
October 21 2020
Study First Post Date:
2020-10-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-08-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-13
Last Update Post Date:
2023-08-03
Last Update Post Date Type:
ACTUAL